Navigation Links
New Parkinson's Treatment Shows Promise in Animals
Date:3/19/2009

g Parkinson's symptoms than stimulating the cells in that region of the brain itself.

Because the axons lie closer to the surface of the brain, it's possible the discovery will lead to new, less invasive techniques, researchers said.

"Because these axons are coming from areas closer to the brain's surface, new treatments could perhaps be less invasive than deep brain stimulation," said Dr. Karl Deisseroth, senior study author and an associate professor of bioengineering, psychiatry and behavioral sciences at Stanford University.

More information

The National Parkinson Foundation has more about symptoms and treatments for the disease.



SOURCES: Miguel Nicolelis, M.D., Ph.D., professor, neuroscience, Duke University Medical Center, Durham, N.C.; Michael Okun, M.D., national medical director, National Parkinson Foundation; March 19, 2009, Science Express, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. New treatment boosts muscle function in myasthenia gravis
3. Broad-based group of physicians calls for improvement in stroke treatment
4. Cranberry Could Juice Up Ovarian Cancer Treatment
5. Non-medicinal treatment touted for pre-schoolers with ADHD
6. Nonmedicinal treatment touted for preschoolers with ADHD
7. U of M study: Early treatment can reverse heart damage
8. Biologic treatment for rheumatoid arthritis and the risk of cancer
9. New Treatment Explored for Cluster Headaches
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Parkinson's Treatment Shows Promise in Animals
(Date:3/1/2015)... 2015 Adults who are not legally ... term or universal policies can now use the QuotesPros.com ... life insurance companies for single adults can now be ... http://quotespros.com/life-insurance.html . , The rate plans that nationwide agencies ... to a number of life protection policies. The term, ...
(Date:3/1/2015)... 01, 2015 A federal court ... ) scheduled to go to trial in October ... witness to provide testimony regarding the role an ... the Profemur device, Bernstein Liebhard LLP comments. According ... Northern District of Iowa on February 25th, Wright ...
(Date:3/1/2015)... March 01, 2015 The number of ... over the past few weeks in two New Jersey ... filing claims, the Firm announces. , A Case ... in the Bergen County proceeding established for products manufactured ... a few weeks earlier, when 90 fewer cases had ...
(Date:3/1/2015)... ERISAPros is pleased to announce ... the professional staff of its Compliance Department. , Evelyn ... State University-Mortiz College of Law. Prior to joining ERISAPros, ... several Fortune 500 companies as well as several privately ... Her experiences range from benefit plan design, vendor management, ...
(Date:3/1/2015)... 01, 2015 Theme and plugin developers ... transition pack for Final Cut Pro X entitled ... transitions to any FCPX editors project.” Said Christiana Austin, ... the tools needed to easily drag and drop their ... gets many different controls over the parameters of this ...
Breaking Medicine News(10 mins):Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2
... Experience with Complex Rehab Market , , ... rehab specialist with 35 years of experience, has joined ... fastest growing complex rehab companies. O,Neill is an Assistive ... www.alliance-seating.com ) and is responsible for sales and service of ...
... muscular atrophy, a neurodegenerative disorder that causes the weakening ... and occurs in 1 in 6,000 live births. ... impressive results as a treatment for spinal muscular atrophy ... to translate the therapy to the human body. A ...
... Mo. Evolving HIV viral strains and the adverse ... treatments propel scientists to continue exploring alternative HIV ... Missouri researcher has identified broad-spectrum aptamers. Aptamers are ... reproducing. In lab tests, aptamers known as RT5, ...
... TriCipher will host an,informative Webinar detailing ... pharmaceutical and health care industries and strategies,for securing ... one hour webinar on December 16th brings together ... discuss how digital signatures have,benefited and streamlined research ...
... of voriconazole in combating fungal infections has been confirmed ... International Journal of Antimicrobial Agents ( www.elsevier.com/locate/ijaa ... with weakened immune systems, which can be caused by ... reinforces earlier findings that this drug is a potent ...
... Dec. 16 WellPoint, Inc. (NYSE: WLP ... today,announced plans to collaboratively partner with four Blue Cross ... to online, consumer-friendly,health care cost information. , ... WellPoint in this initiative are,Highmark Inc. (Pennsylvania), Premera Blue ...
Cached Medicine News:Health News:Veteran Rehab Specialist, Ted O'Neill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania 2Health News:Researcher refining synthetic molecules to prevent HIV resistance 2Health News:Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures 2Health News:Pharmaceutical and Health Care Experts to Detail Cost-Cutting Capabilities of Secure Digital Signatures 3Health News:Voriconazole: A highly potent treatment for fungal infections 2Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 2Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 3Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 4
(Date:2/27/2015)... MARLTON, N.J. , Feb. 27, 2015  Acsis ... collaboration and serialization solutions, announced today that John ... as a Supply & Demand Chain Executive ... chain executives who are leading initiatives to help prepare ... challenges of today,s business climate. This year,s list of ...
(Date:2/27/2015)... 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... pro forma net operating loss (NOL) guidance and its ... position.  Isis, significantly improved financial results were due in ... payments the Company received from its partners.  Isis, pro ... nearly 60% improvement over its 2013 NOL of $40.2 ...
(Date:2/27/2015)... 2015 Report Details   ... trends, R&D progress, and predicted revenues ,Where is the ... the commercial prospects for this market and related technologies? ... other trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... May 10, 2011 Omeros Corporation (NASDAQ: ... and commercializing products focused on inflammation, coagulopathies and disorders ... results for the first quarter of 2011. ... ended March 31, 2011 were $7.7 million compared to ...
... 2011 Pierrel Research USA, Inc. ( www.pierrel-research-usa.com ... global pharmaceutical services company ( www.pierrel.it ), announces ... with epinephrine 1:100,000 and Articaine hydrochloride 4% with ... of Articaine with epinephrine, an injectable dental anesthetic ...
Cached Medicine Technology:Omeros Corporation Reports First Quarter 2011 Financial Results 2Omeros Corporation Reports First Quarter 2011 Financial Results 3Omeros Corporation Reports First Quarter 2011 Financial Results 4Pierrel Research USA Launches Orabloc™ a New Purer Articaine 2Pierrel Research USA Launches Orabloc™ a New Purer Articaine 3
For the detection of pan specific pLDH, utilizing whole blood samples. Parabank excludes infected blood from the blood supply in the blood bags....
192 Test Enzyme Immunoassay for the detection of Human IgG antibodies to all four forms of Malaria....
ADVANTAGE MALARIA STIX is a visual, rapid and sensitive immunoassay for the qualitative differential detection of P.falciparum (P.f) and P.vivax (P.v) malaria in Human Blood only....
Malaria device / strip (2 line, PAN specific-pLDH)...
Medicine Products: